Status: current, Defined. Date: 30-Jun 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4407361000168111 | Xativa (cannabidiol 12.5 mg) sublingual wafer (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4407371000168117 | Xativa 12.5 mg sublingual wafer | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Xativa 12.5 mg sublingual wafer | Is a | Xativa | true | Inferred relationship | Some | ||
| Xativa 12.5 mg sublingual wafer | Is a | cannabidiol 12.5 mg sublingual wafer | true | Inferred relationship | Some | ||
| Xativa 12.5 mg sublingual wafer | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Xativa 12.5 mg sublingual wafer | has manufactured dose form | sublingual wafer | true | Inferred relationship | Some | ||
| Xativa 12.5 mg sublingual wafer | has Australian BoSS | cannabidiol | true | Inferred relationship | Some | 1974436828 | |
| Xativa 12.5 mg sublingual wafer | has intended active ingredient | cannabidiol | true | Inferred relationship | Some | 1974436828 | |
| Xativa 12.5 mg sublingual wafer | has unit of use | wafer | true | Inferred relationship | Some | 107631464 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Xativa 12.5 mg sublingual wafer, 30 | has TPUU | True | Xativa 12.5 mg sublingual wafer | Inferred relationship | Some | 1512177763 |
| Xativa 12.5 mg sublingual wafer, 30, blister pack | has TPUU | True | Xativa 12.5 mg sublingual wafer | Inferred relationship | Some | 1331119573 |
Reference Sets
Trade product unit of use reference set
FHIR